Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-04 · 1880 (2) · 189292
DOI: 10.1016/j.bbcan.2025.189292 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-04. Verfasst von Mrudula Gore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Oncogene Proteins, Viral, Papillomavirus Infections, Papillomaviridae. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance.
Abstract (Originalsprache)
The role of human Papillomavirus (HPV) in metabolic reprogramming is implicated in the development and progression of cervical cancer. During carcinogenesis, cancer cells modify various metabolic pathways to generate energy and sustain their growth and development. Cervical cancer, one of the most prevalent malignancies affecting women globally, involves metabolic alterations such as increased glycolysis, elevated lactate production, and lipid accumulation. The oncoproteins, primarily E6 and E7, which are encoded by high-risk HPVs, facilitate the accumulation of several cancer markers, promoting not only the growth and development of cancer but also metastasis, immune evasion, and therapy resistance. HPV oncoproteins interact with cellular MYC (c-MYC), retinoblastoma protein (pRB), p53, and hypoxia-inducible factor 1α (HIF-1α), leading to the induction of metabolic reprogramming and favour the Warburg effect. Metabolic reprogramming enables HPV to persist for an extended period and accelerates the progression of cervical cancer. This review summarizes the role of HPV oncoproteins in metabolic reprogramming and their contributions to the development and progression of cervical cancer. Additionally, this review provides insights into how metabolic reprogramming opens avenues for novel therapeutic strategies, including the discovery of new and repurposed drugs that could be applied to treat cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
- Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Electronic address: shama.prasada@manipal.edu.
- Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
Förderung
- Wellcome Trust
- DBT-Wellcome Trust India Alliance
Zitieren
APA
Gore, M., Kabekkodu, S. P., & Chakrabarty, S. (2025). Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(2), 189292. https://doi.org/10.1016/j.bbcan.2025.189292
Vancouver
Gore M, Kabekkodu SP, Chakrabarty S. Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(2):189292. doi:10.1016/j.bbcan.2025.189292
BibTeX
@article{Gore2025,
author = {Gore, Mrudula and Kabekkodu, Shama Prasada and Chakrabarty, Sanjiban},
title = {Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {2},
pages = {189292},
doi = {10.1016/j.bbcan.2025.189292}
}
EUVIMED